Phenoxymethylpenicillin

ApprovedSmall molecule

UUniversity of Aarhus

Phenoxymethylpenicillin is one of 39 small molecule programs targeting Cellulitis. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CellulitisActive, not recruiting

ErythemaActive, not recruiting

CellulitisApproved

Active, not recruiting

ErythemaApproved

Active, not recruiting

Competition

Competitive Landscape

50 competitors in Erythema

#DrugCompanyPhaseTrials

Trexall

Alnylam Pharmaceuticals

Approved

1 2

Lamprene

Novartis

Approved

1 3

Vibramycin

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

7 4

Accutane

CConrado Roberto Hoffmann Filho

Approved

1 5

Amoxil

GGlobal Antibiotics Research and Development Partnership

Approved

1 6

Trimethoprim-Sulfamethoxazole

Astellas

Approved

1 7

Botulinum Toxin a

GSK

Approved

1 8

Alphagan

Novartis

Phase 3

1 9

Ceftin

GGlaxo Dba Glaxosmithkline

Approved

2 10

Rhofade

KKenvue Brands

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Sore Throat2 trials

Sore Throat in Primary Care - a Comparison of Phenoxymethylpenicillin and No Antibiotic Treatment

Recruiting·KKatarina Hedin·Phase 4·NCT04083417·260 enrolled

Study of 5 and 10 Days Treatment With Penicillin Against Sore Throat Caused by Streptococci

Completed·AAss. Prof. Katarina Hedin·Phase 4·NCT02712307·433 enrolled

Gut Microbiota1 trial

Effects of Phenoximethylpenicillin, Amoxicillin and Amoxicillin-clavulanic Acid on the Gut Microbiota

Completed·UUppsala University·Phase 4·NCT04084106·104 enrolled

Children1 trial

A Pharmacokinetic and Pharmacodynamic Study of Phenoxymethylpenicillin for Children

Completed·UUniversity of Aarhus·Phase 1·NCT01499875·80 enrolled

Cellulitis1 trial

Penicillin for the Emergency Department Outpatient Treatment of CELLulitis

Unknown status·RRoyal College of Surgeons, Ireland·Phase 4·NCT02922686·414 enrolled

Erythema1 trial

Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice

Completed·MMorten Lindbaek·Phase 4·NCT01368341·225 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Phenoxymethylpenicillin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Phenoxymethylpenicillin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Phenoxymethylpenicillin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Aarhus company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UUniversity of Aarhus

Phenoxymethylpenicillin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Sore Throat2 trials

Gut Microbiota1 trial

Children1 trial

Cellulitis1 trial

Erythema1 trial

References

Drug Info

Quick Facts

Related News